Log in to save to my catalogue

Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?

Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_469928

Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?

About this item

Full title

Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?

Publisher

New York: Springer US

Journal title

Journal of thrombosis and thrombolysis, 2021-01, Vol.51 (1), p.226-231

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has been linked to a higher risk of mortality compared to influenza, which is mainly due to severe secondary diseases, such as acute respiratory distress syndrome (ARDS). In turn, ARDS is characterized by an acute inflammation and an excessive activity of the coagulation cascade...

Alternative Titles

Full title

Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_swepub_ki_se_469928

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_469928

Other Identifiers

ISSN

0929-5305

E-ISSN

1573-742X

DOI

10.1007/s11239-020-02212-6

How to access this item